image_pdfimage_print

Frequently Asked Questions (FAQs)

How is this program different? 

The HARC Intensive Comprehensive Aphasia Program (ICAP) was designed to promote life participation and functional communication through individualized, evidence-based, 1:1 therapy. We have identified the best practices from around the country for intensive aphasia programs and have created our program based on that analysis. Our mission is to use this program to help ICAP participants identify and work toward achieving their personal communication goals in a concentrated period of time. The program is offered Monday through Friday, from 9:00 am to 3:00 pm for four weeks. Participants will receive 20 hours of speech and language therapy each week.   

 

Is an ICAP right for me?

Research indicates that individuals with aphasia benefit from intensive treatment provided over a short period of time. The HARC ICAP is an individualized, intensive therapy program designed to maximize communication potential and improve life participation through tailored restorative and compensatory intervention approaches. Our ICAP was designed to cover many aspects of communication including reading, writing, speaking, and understanding.

 

How much time is each day spent in individual 1:1 sessions?

Participants will receive 3 hours of 1:1 therapy and 1 hour of group-based therapy per day.

 

Why is this not covered under insurance?

Medicare limits coverage to one hour a day, and this intensive program is above and beyond what Medicare will cover. HARC does not bill insurance for the intensive program.

 

Does my caregiver or spouse participate in the sessions with me?

The HARC ICAP therapy sessions are for the participant; however, education and feedback will be provided as needed. Each participant will complete a pre-evaluation and post-evaluation in which we will ask a family member or caregiver to participate. This will help us to tailor each participant’s program to their individual needs as well as their families wishes for treatment.

 

Â